A total of 122 patients (91 children, 31 adults) underwent transplantation with unrelated CB from the CB bank in Düsseldorf between October 1996 and 2003 in 21 countries at 60 transplant centres (20 ...

The success of allogeneic hematopoietic stem cell transplantation depends in part on the accuracy of human leukocyte antigen (HLA) matching between the donor–recipient pair. The higher the number of ...

This study did not confirm that UHR 12 out of 12 HLA matching increases the probability of overall survival but does demonstrate that aGVHD risk, and in certain settings TRM, is lowest in UHR ...

March 1, 2011 (Vol. 31, No. 5)Advances in Extractin and Enzymology Open Door for RNA as Alternative to Genomic DNA The Tissue Typing Laboratory tests for compatibility between patients who require an ...

OSLO, Norway--(BUSINESS WIRE)--NEC OncoImmunity AS (NOI) today announced a publication that describes a novel approach to type new HLA alleles and characterize the HLA of tumors to guide personalized ...

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of ...

Matching donors for stem cell transplantation demands both precision and speed, especially as requests for high-resolution human leukocyte antigen (HLA) data grow. As labs adapt to higher workloads ...

The human leukocyte antigen (HLA) system has an important role in the regulation of the immune system; the HLA recognizes cells as ‘non-self’ or ‘self’ to prevent the body from attacking its own cells ...

Evaluation of previous HLA typing for the Fred Hutchinson Cancer Center Clinical Coordinator Office prior to consult appointments (includes review of CIL and outside lab typing). Review and advice on ...

Austin, May 27, 2025 (GLOBE NEWSWIRE) -- HLA Typing Market Size & Growth Analysis: According to SNS Insider, Global HLA Typing Market value was USD 1.62 billion in 2024 and is estimated to grow at a ...

SSPGo products require only the addition of DNA to the room temperature-stable reaction mix. Molecular diagnostics firm Biofortuna inked an exclusive deal with Abbott’s molecular diagnostics business ...